Artificially Modified NK Cell-Based Synergistic Immuno-Gene-Photodynamic Therapy for Cancer

Artificially Modified NK Cell-Based Synergistic Immuno-Gene-Photodynamic Therapy for Cancer

Jiale Wu,1,2 Kaihong Shi,1,2 Wei Chao,1,2 Zeyu Qin,1,2 Youhui Hu,1,2 Yihua Yang,1,2 Yuan He,1,2 Yabing Hua,1,2 Ziming Zhao1,2 1Department of Pharmacy, Xuzhou Medical University, Xuzhou, People’s Republic of China; 2Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical Uni...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wu J, Shi K, Chao W, Qin Z, Hu Y, Yang Y, He Y, Hua Y, Zhao Z
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-11-01
Series:	International Journal of Nanomedicine
Subjects:	natural killer cells photo-responsive tme-responsive anticancer cellular immunotherapy nanogel
Online Access:	https://www.dovepress.com/artificially-modified-nk-cell-based-synergistic-immuno-gene-photodynam-peer-reviewed-fulltext-article-IJN
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Manganese oxide nanomaterials: bridging synthesis and therapeutic innovations for cancer treatment
by: Sandip Gangadhar Balwe, et al.
Published: (2024-11-01)

Integration of single-cell and bulk RNA-sequencing data to construct and validate a signature based on NK cell marker genes to predict immunotherapy response and prognosis in colorectal cancer
by: Xiaoyu Qin, et al.
Published: (2025-02-01)

Microtubule polymerization induced by iridium‐fullerene photosensitizers for cancer immunotherapy via dual‐reactive oxygen species regulation strategy
by: Xiao‐Xiao Chen, et al.
Published: (2024-12-01)

Precise intracellular uptake and endosomal release of diverse functional mRNA payloads via glutathione-responsive nanogels
by: Rupali Dabas, et al.
Published: (2025-02-01)

Mitochondria-Targeting Type-I Photodynamic Therapy Based on Phenothiazine for Realizing Enhanced Immunogenic Cancer Cell Death via Mitochondrial Oxidative Stress
by: Duan Z, et al.
Published: (2025-01-01)

Precise HER2 Protein Degradation via Peptide‐Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy
by: Changyong Guo, et al.
Published: (2025-01-01)

Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts
by: Farhana Jahan, et al.
Published: (2024-11-01)

DNA vaccines as promising immuno-therapeutics against cancer: a new insight
by: Alireza Shariati, et al.
Published: (2025-01-01)

The future of plant based green carbon dots as cancer Nanomedicine: From current progress to future Perspectives and beyond
by: Hong Hui Jing, et al.
Published: (2025-01-01)

Mouse innate resistance to Neospora caninum infection is driven by early production of IFNγ by NK cells in response to parasite ligands
by: R. S. Coombs, et al.
Published: (2024-11-01)

The anti-inflammatory cytokine IL-37 improves the NK cell-mediated anti-tumor response
by: Nadine Landolina, et al.
Published: (2024-12-01)

Harnessing the Systemic Immunoinflammatory Index as a Potential Predictive Tool for Recurrent or Metastatic Nasopharyngeal Carcinoma Undergoing PD-L1 Inhibitor
by: Song G, et al.
Published: (2024-11-01)

Precursor NK cell lymphoblastic leukemia/lymphoma - report of a case with literature review
by: Sonal Jain, et al.
Published: (2014-08-01)

Angiogenesis and EMT regulators in the tumor microenvironment in lung cancer and immunotherapy
by: Taotao Yan, et al.
Published: (2024-12-01)

Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
by: Shuyan He, et al.
Published: (2025-01-01)

Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route
by: Valentina Mazzotta, et al.
Published: (2024-12-01)

Unsymmetrical Bisacridines’ Interactions with ABC Transporters and Their Cellular Impact on Colon LS 174T and Prostate DU 145 Cancer Cells
by: Monika Pawłowska, et al.
Published: (2024-11-01)

Human NK cells and cancer
by: Claudia Cantoni, et al.
Published: (2024-12-01)

Gold nanorod-based engineered nanogels for cascade-amplifying photothermo-enzymatic synergistic therapy
by: Ling Ding, et al.
Published: (2024-12-01)

Transdermal Delivery of Lornoxicam Hybrid Nanogel: Design, Preparation, Characterization, and In-Vitro Diffusion Evaluation
by: Hayder Kadhim Drais
Published: (2023-10-01)

Emerging Role of Extracellular pH in Tumor Microenvironment as a Therapeutic Target for Cancer Immunotherapy
by: Md Ataur Rahman, et al.
Published: (2024-11-01)

A novel necroptosis-related genes signature to predict prognosis and treatment response in bladder cancer
by: Dongnuan Yao, et al.
Published: (2024-11-01)

Two-dimensional nano-biomaterials in regulating the tumor microenvironment for immunotherapy
by: Guangyu Xu, et al.
Published: (2024-12-01)

Multi-omics analysis and experiments uncover the function of cancer stemness in ovarian cancer and establish a machine learning-based model for predicting immunotherapy responses
by: Zhibing Liu, et al.
Published: (2024-12-01)

Natural killer cell antibody‐dependent cellular cytotoxicity to Plasmodium falciparum is impacted by cellular phenotypes, erythrocyte polymorphisms, parasite diversity and intensity of transmission
by: Stephen Tukwasibwe, et al.
Published: (2024-01-01)

Contradictory Effect of Lymphocyte Therapy and Prednisolone Therapy on CD3+CD8+CD56+ Natural Killer T Population in Women with Recurrent Spontaneous Abortion
by: Fatemeh Rezayat, et al.
Published: (2023-07-01)

scRNA-Seq Analysis Revealed CAFs Regulating HCC Cells via PTN Signaling
by: Lin W, et al.
Published: (2024-11-01)

RNA modification writer-based immunological profile and genomic landscape of tumor microenvironment in lung adenocarcinoma
by: Qiang Xu, et al.
Published: (2025-01-01)

Trying to Kill a Killer; Impressive Killing of Patient Derived Glioblastoma Cultures Using NK-92 Natural Killer Cells Reveals Both Sensitive and Highly Resistant Glioblastoma Cells
by: Jane Yu, et al.
Published: (2025-01-01)

Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts
by: Yaya Chu, et al.
Published: (2024-06-01)

Natural killer cell memory: challenges and opportunities for cancer immunotherapy
by: Yuhua Qu, et al.
Published: (2024-12-01)

The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances
by: Pin Yao, et al.
Published: (2024-12-01)

MAP17 is a Novel NASH Progression Biomarker Associated with Macrophage Infiltration, Immunotherapy Response, and Oxidative Stress
by: Huang Z, et al.
Published: (2025-01-01)

Exosomes: Key Messengers Mediating the Interaction Between Tumor Cells and CD8+ T Cells in the Tumor Microenvironment
by: Li Y, et al.
Published: (2025-01-01)

Recent advances and perspectives of multifunctional nanogels in biomedical applications
by: Bicheng Han, et al.
Published: (2024-12-01)

Antimicrobial effects of nanocurcumin gel on reducing the microbial count of gingival fluids of implant‒abutment interface: A clinical study
by: Mohammad Ali Ghavimi, et al.
Published: (2022-12-01)

Bio-Composite Nanogels Based on Chitosan and Hyaluronic Acid for the Treatment of Lung Infections
by: Francesca Della Sala, et al.
Published: (2024-11-01)

Formulation and Evaluation of Different Nanogels of Tapinarof for Treatment of Psoriasis
by: Barbara Balogh, et al.
Published: (2024-10-01)

Oral creatine-modified selenium-based hyaluronic acid nanogel mediated mitochondrial energy recovery to drive the treatment of inflammatory bowel disease
by: Manxiu Huai, et al.
Published: (2024-11-01)

ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation
by: Jiaxing Zhang, et al.
Published: (2025-02-01)